(Q40788018)

English

Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Is lipoprotein(a)-cholesterol a better predictor of vascular disease events than total lipoprotein(a) mass? A nested case control study from the West of Scotland Coronary Prevention Study (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

0 references

1 reference

based on heuristic

inferred from title

vascular disease

1 reference

based on heuristic

inferred from title

author name string

Gaw A

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Brown EA

2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Docherty G

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ford I

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 January 2000

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Atherosclerosis

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

148

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

95-100

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Apo(a) isoforms predict risk for coronary heart disease. A study in six populations

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Lp(a) lipoprotein as a risk factor for myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Elevated plasma lipoprotein(a) and coronary heart disease in men aged 55 years and younger. A prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Lipoprotein(a), atherosclerosis and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Lipoprotein (a) and coronary heart disease risk: a nested case-control study of the Helsinki Heart Study participants

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Lipoproteins and their genetic variation in subjects with and without angiographically verified coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Lipoprotein(a) and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Lipoprotein Lp(a) as predictor of myocardial infarction in comparison to fibrinogen, LDL cholesterol and other risk factors: results from the prospective Göttingen Risk Incidence and Prevalence Study (GRIPS).

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Evaluation of a new automated latex agglutination assay for lipoprotein(a): comparison with a manual ELISA

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9150%2899%2900259-2

7 January 2021

Identifiers

10.1016/S0021-9150(99)00259-2

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40788018&oldid=1907373680"